📣 VC round data is live. Check it out!

Kweichow Moutai Valuation Multiples

Discover revenue and EBITDA valuation multiples for Kweichow Moutai and similar public comparables like LVMH, AB InBev, Ambev, Wuliangye and more.

Kweichow Moutai Overview

About Kweichow Moutai

Kweichow Moutai is one of China's leading liquor producers. The company was established in 1951 and its headquarters are located in Moutai Town, Guizhou province, southwest China. Its flagship product, 53-degree Feitian Moutai, is known as China's national drink and has been consumed during many high-profile historical and political events. Given its remarkable pricing power, premium product quality, and unparalleled brand strength, the company achieves the industry's highest retail prices and profit margins. The state-owned Assets Supervision and Administration Commission of Guizhou province through Moutai Group controls a 49% stake in Kweichow Moutai.


Founded

1999

HQ

China

Employees

34.8K

Sectors

Financials (LTM)

Revenue: $26B
EBITDA: $17B

EV

$230B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Kweichow Moutai Financials

Kweichow Moutai reported last 12-month revenue of $26B and EBITDA of $17B.

In the same LTM period, Kweichow Moutai generated $23B in gross profit, $17B in EBITDA, and $12B in net income.

Revenue (LTM)


Kweichow Moutai P&L

In the most recent fiscal year, Kweichow Moutai reported revenue of $25B and EBITDA of $17B.

Kweichow Moutai is profitable as of last fiscal year, with gross margin of 91%, EBITDA margin of 68%, and net margin of 48%.

See analyst estimates for Kweichow Moutai
LTMLast FY202320242025202620272028
Revenue$26B$25B$22B$26B$25B
Gross Profit$23B$23B$20B$24B$23B
Gross Margin91%91%92%92%91%
EBITDA$17B$17B$16B$18B$17B
EBITDA Margin67%68%70%70%68%
EBIT Margin66%66%68%68%66%
Net Profit$12B$12B$11B$13B$12B
Net Margin48%48%50%50%48%

Financial data powered by Morningstar, Inc.

Kweichow Moutai Stock Performance

Kweichow Moutai has current market cap of $237B, and enterprise value of $230B.

Market Cap Evolution


Kweichow Moutai's stock price is $189.25.

Kweichow Moutai share price decreased by 6.6% in the last 30 days, and by 14.4% in the last year.

Kweichow Moutai has an EPS (earnings per share) of $9.67.

See more trading valuation data for Kweichow Moutai
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$230B$237B-0.2%-6.6%-11.3%-14.4%$9.67

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Kweichow Moutai Valuation Multiples

Kweichow Moutai trades at 8.9x EV/Revenue multiple, and 13.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Kweichow Moutai

EV / Revenue (LTM)


Kweichow Moutai Financial Valuation Multiples

As of May 27, 2026, Kweichow Moutai has market cap of $237B and EV of $230B.

Kweichow Moutai has a P/E ratio of 19.2x.

LTMLast FY202320242025202620272028
EV/Revenue8.9x9.1x10.4x9.0x9.1x
EV/EBITDA13.3x13.3x14.8x12.8x13.3x
EV/EBIT13.5x13.7x15.3x13.2x13.7x
EV/Gross Profit9.8x9.9x11.3x9.7x9.9x
P/E19.2x19.6x21.5x18.7x19.6x
EV/FCF23.8x26.7x24.4x17.8x26.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Kweichow Moutai Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Kweichow Moutai Margins & Growth Rates

Kweichow Moutai grew revenue by 4% and EBITDA by 4% in the last fiscal year.

In the most recent fiscal year, Kweichow Moutai reported gross margin of 91%, EBITDA margin of 68%, and net margin of 48%.

See estimated margins and future growth rates for Kweichow Moutai

Kweichow Moutai Margins

Last FY202420252026202720282029
Gross Margin91%92%91%91%
EBITDA Margin68%70%68%68%
EBIT Margin66%68%66%67%
Net Margin48%50%48%48%
FCF Margin34%50%34%48%

Kweichow Moutai Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%16%(1%)4%
Gross Profit Growth4%16%(2%)4%
EBITDA Growth4%15%(4%)4%
EBIT Growth5%16%(4%)5%
Net Profit Growth5%15%(5%)5%
FCF Growth49%37%(33%)49%

Data powered by FactSet, Inc. and Morningstar, Inc.

Kweichow Moutai Operational KPIs

Kweichow Moutai's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.2M for the same period.

Kweichow Moutai's Rule of 40 is 72% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Kweichow Moutai's Rule of X is 79% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Kweichow Moutai
LTMLast FY202320242025202620272028
Rule of 4073%72%---
Bessemer Rule of X81%79%---
Revenue per Employee-$0.7M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue4%4%3%3%4%
G&A Expenses to Revenue5%5%3%3%3%
R&D Expenses to Revenue0%0%0%0%0%
Opex to Revenue-25%24%24%25%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Kweichow Moutai Competitors

Kweichow Moutai competitors include LVMH, AB InBev, Ambev, Wuliangye, Diageo, Heineken, Backus, Constellation Brands and Xinghuacun Fenjiu.

Most Kweichow Moutai public comparables operate across Alcohol.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
LVMH3.1x3.2x10.0x10.7x
AB InBev3.8x3.6x10.5x10.1x
Ambev2.7x2.7x8.3x8.1x
Wuliangye5.0x4.3x15.1x12.9x
Diageo3.4x3.5x10.0x10.7x
Heineken1.8x1.8x8.2x7.9x
Backus----

This data is available for Pro users. Sign up to see all Kweichow Moutai competitors and their valuation data.

Start Free Trial

Kweichow Moutai Investment Activity

Kweichow Moutai has invested in 3 companies to date.

Latest investment by Kweichow Moutai was on March 21st 2026. Kweichow Moutai invested in Zhishen Technology in their Series B round.

See VC round multiples

Latest Investments by Kweichow Moutai

Zhishen Technology
Jize Biotech
Synaura
Description
Zhishen Technology is a specialist in embodied intelligence, developing technologies for physical AI interactions.
Jize Biotech is a Shanghai-headquartered biotechnology firm specializing in the development and commercialization of synthetic bear bile powder as an ethical alternative to traditional sources. It advances sustainable biomedical products through rigorous research, standardized manufacturing, and innovative processes.
Shanghai-based Synaura is a biotechnology company producing human milk oligosaccharides through biosynthesis for infant formula additives. Its HMOs replicate structures found in breast milk, supporting immune development and gut health in formula-fed babies.
HQ CountryChinaChinaChina
HQ City
-
-
Shanghai
Deal Date21 Mar 20264 Dec 20259 May 2024
RoundSeries BSeries ASeed
Raisedundisclosedundisclosed$14M
InvestorsKweichow MoutaiFujian Guoli Minsheng; Kweichow MoutaiChina Mengniu Dairy; CICC Qide; Kweichow Moutai; Zhongjin Qide
Valuationundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Kweichow Moutai investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Kweichow Moutai

When was Kweichow Moutai founded?Kweichow Moutai was founded in 1999.
Where is Kweichow Moutai headquartered?Kweichow Moutai is headquartered in China.
How many employees does Kweichow Moutai have?As of today, Kweichow Moutai has over 34K employees.
Is Kweichow Moutai publicly listed?Yes, Kweichow Moutai is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of Kweichow Moutai?Kweichow Moutai trades under 600519 ticker.
When did Kweichow Moutai go public?Kweichow Moutai went public in 2001.
Who are competitors of Kweichow Moutai?Kweichow Moutai main competitors include LVMH, AB InBev, Ambev, Wuliangye, Diageo, Heineken, Backus, Constellation Brands, Xinghuacun Fenjiu.
What is the current market cap of Kweichow Moutai?Kweichow Moutai's current market cap is $237B.
What is the current revenue of Kweichow Moutai?Kweichow Moutai's last 12 months revenue is $26B.
What is the current revenue growth of Kweichow Moutai?Kweichow Moutai revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Kweichow Moutai?Current revenue multiple of Kweichow Moutai is 8.9x.
What is the current EBITDA of Kweichow Moutai?Kweichow Moutai's last 12 months EBITDA is $17B.
What is Kweichow Moutai's EBITDA margin?Kweichow Moutai's last 12 months EBITDA margin is 67%.
What is the current EV/EBITDA multiple of Kweichow Moutai?Current EBITDA multiple of Kweichow Moutai is 13.3x.
What is the current FCF of Kweichow Moutai?Kweichow Moutai's last 12 months FCF is $10B.
What is Kweichow Moutai's FCF margin?Kweichow Moutai's last 12 months FCF margin is 38%.
What is the current EV/FCF multiple of Kweichow Moutai?Current FCF multiple of Kweichow Moutai is 23.8x.
How many companies Kweichow Moutai has acquired to date?Kweichow Moutai hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Kweichow Moutai has invested to date?As of May 2026, Kweichow Moutai has invested in 3 companies.
What was the last Kweichow Moutai investment?On 21st March 2026 Kweichow Moutai invested in Zhishen Technology, participating in a Series B round.
In what companies Kweichow Moutai invested in?Kweichow Moutai invested in Synaura, Zhishen Technology, and Jize Biotech.

See public comps similar to Kweichow Moutai

Lists including Kweichow Moutai

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial